CASE DESCRIPTION
================

A 50-year-old woman presented with a 3-month history of post-prandial abdominal cramping, vomiting and a 7 lb weight loss. Her medical history was significant for hypertension, hyperlipidaemia, depression, chronic obstructive pulmonary disease (COPD) and gastroesophageal reflux disease. There was no history of HIV (human immunodeficiency virus) or diabetes. She denied non-steroidal anti-inflammatory drug (NSAID) use and alcohol consumption and was not taking corticosteroids. Endoscopic evaluation was performed.

Esophagogastroduodenoscopy (EGD) revealed a 1 cm, non-bleeding, irregular-shaped, deep and clean-based ulcer at the pylorus ([Fig. 1](#f1-1696-1-13537-1-10-20200519){ref-type="fig"}). The remainder of the examination was unremarkable. Biopsies were taken and revealed an ulcer with necro-inflammatory debris and fungal organisms, consistent with *Candida* species ([Fig. 2](#f2-1696-1-13537-1-10-20200519){ref-type="fig"}). Periodic acid-Schiff (PAS) fungal stain revealed scattered yeast colonizing the fibrinous debris ([Fig. 3](#f3-1696-1-13537-1-10-20200519){ref-type="fig"}).

The patient was given a 3-week course of fluconazole and her symptoms had resolved on follow-up. Repeat EGD (2 months later) revealed resolution of her ulcer ([Fig. 4](#f4-1696-1-13537-1-10-20200519){ref-type="fig"}). Repeat biopsies of the pylorus were negative for any evidence of fungal organisms ([Fig. 5](#f5-1696-1-13537-1-10-20200519){ref-type="fig"}).

DISCUSSION
==========

Peptic ulcers are breaks in the gastric or duodenal mucosa which penetrate through the muscularis mucosa and create a cavity with surrounding inflammation. Peptic ulcer disease (PUD) is the most common cause of stomach and duodenal perforation. Worldwide, there were 87.4 million new cases of peptic ulcers in 2015 resulting in 267,500 deaths ^\[[@b1-1696-1-13537-1-10-20200519]\]^. PUD affects more than 6 million people in the USA each year ^\[[@b2-1696-1-13537-1-10-20200519]\]^.

A large, retrospective study using the National Inpatient Sample consisting of US inpatient data between 1998 and 2005 showed an average annual PUD hospitalization rate of 63.6/100,000 population.

Helicobacter pylori infection and NSAID use are responsible for the overwhelming majority of PUD cases. However, improved detection with endoscopy has reduced *H. pylori* prevalence. Other causes of non-H. pylori non-NSAID ulcers include antiplatelet drugs, stress, *Helicobacter heilmannii*, cytomegalovirus, Behçet's disease, Zollinger-Ellison syndrome, Crohn's disease and cirrhosis with portal hypertension ^\[[@b3-1696-1-13537-1-10-20200519]\]^. Risk factors for the development of PUD are the use of NSAIDs, H. pylori, COPD, chronic renal insufficiency and tobacco use. Even though fungal PUD has a prevalence of 4--36%, the diagnosis is frequently overlooked ^\[[@b4-1696-1-13537-1-10-20200519]\]^.

*Candida* is a normal commensal organism in the gut and colonizes the oesophagus in 20% of healthy adults ^\[[@b5-1696-1-13537-1-10-20200519]\]^. Few cases of fungal PUD in immunocompetent patients have been reported over the past 10 years ([Table 1](#t1-1696-1-13537-1-10-20200519){ref-type="table"}). A review of 16 patients between 1998 and 2007 at a university hospital in Korea revealed that nine cases of gastric candidiasis were benign ulcers and the other seven were malignant. Similar to previous literature, associated conditions included diabetes, cirrhosis, lung cancer and pulmonary tuberculosis ^\[[@b6-1696-1-13537-1-10-20200519]\]^.

A literature review yielded 10 cases of fungal PUD in immunocompetent patients with risk factors such as smoking, steroid use and heavy antacid use. Antifungal treatment resulted in clinical improvement and ulcer resolution in eight of the 10 patients. One patient, with a perforated fungal ulcer, died post-operatively after cardiac arrest and did not receive any medication. Another patient refused treatment and interestingly was found to have a recurrent Candida-associated gastric ulcer in a different location. One patient was found to have H. pylori on an initial biopsy of a peptic ulcer, followed by Candida albicans on the second endoscopy. Two patients had co-existing infection with both *H. pylori* and *C. albicans* and were both successfully treated with an antifungal agent and a proton-pump inhibitor. Patients with large ulcers may have fungal PUD. Overall, the treatments were varied as regards lengths of treatment and antifungal agents which included fluconazole, caspofungin and amphotericin B ([Table 1](#t1-1696-1-13537-1-10-20200519){ref-type="table"}). Our patient eventually achieved clinical and biopsy-proven resolution after completing a course of fluconazole, providing more evidence for the use of antifungals in the treatment of *Candida PUD.*

CONCLUSION
==========

We present a case of EGD and biopsy-proven resolution of PUD secondary to *Candida* infection in an immunocompetent patient. It is important for clinicians to maintain a higher index of suspicion for other causes of PUD for correct and prompt management.
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###### 

Published cases of fungal peptic ulcer disease

                                                                  *Patient age, gender*   *Presentation*                                           *Risk factors*                       *Endoscopy*                                                                                                         *Histopathology/culture*                                                                                                       *Treatment*                                                                                                         *Outcome*
  --------------------------------------------------------------- ----------------------- -------------------------------------------------------- ------------------------------------ ------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------
  *Cascio et al, 2011^\[[@b7-1696-1-13537-1-10-20200519]\]^*      *62, M*                 *Severe epigastric pain*                                 *Heavy smoker*                       *None. Ex-lap with 2.5 cm wide perforation of duodenal bulb*                                                        *Candida krusei on biopsy and peritoneal fluid culture*                                                                        *Caspofungin*                                                                                                       *Resolution*
  *Nishimura et al, 2011^\[[@b8-1696-1-13537-1-10-20200519]\]^*   *73, F*                 *Unknown (article in Japanese)*                          *None*                               *Two gastric ulcers with thick exudates in the fornix*                                                              *Numerous Candida forms*                                                                                                       *Antifungal*                                                                                                        *Resolution*
  *Nagata et al, 2012^\[[@b9-1696-1-13537-1-10-20200519]\]^*      *82, M*                 *Epigastric pain*                                        *None*                               *Ulcerous lesions with thick exudates in the fornix and corpus and severe atrophic gastritis*                       *Candida forms and Helicobacter pylori (confirmed with 13C breath test)*                                                       *Antifungal and PPI*                                                                                                *Resolution*
  *Rai et al, 2012^\[[@b10-1696-1-13537-1-10-20200519]\]^*        *25, F*                 *Upper abdominal pain, cough, fever*                     *None*                               *Oval to circular 10×6 cm ulcer*                                                                                    *1st EGD - H. pylori; 2nd EDG - granulation tissue, numerous yeast and pseudohyphae on PAS consistent with Candida albicans*   *Amphotericin B+PPI*                                                                                                *Survived; following EGD normal*
  *Sasaki, 2012^\[[@b11-1696-1-13537-1-10-20200519]\]^*           *87, F*                 *Anorexia*                                               *Steroid inhaler use, risedronate*   *Medium-sized submucosal tumour-like elevation covered with erythematous mucosa with an oval, deep central ulcer*   *Large number of hyphae; Candida tropicalis by culture*                                                                        *None*                                                                                                              *Recurrent Candida-associated gastric ulcer*
  *Gupta, 2012^\[[@b12-1696-1-13537-1-10-20200519]\]^*            *50, M*                 *Sudden onset abdominal pain and shock*                  *Strong antacid intake*              *None. Ex-lap with 1×1 cm prepyloric perforation*                                                                   *Pseudohyphae, suggestive of Candida; peritoneal fluid with C. albicans*                                                       *Not given antifungal treatment*                                                                                    *Died from cardiac arrest*
  *Ince et al, 2014^\[[@b13-1696-1-13537-1-10-20200519]\]^*       *55, M*                 *Haematemesis and melena*                                *None*                               *Giant gastric ulcer (4 cm diameter) with oozing visible vessel on yellow base in corpus region*                    *H. pylori and positive PAS; C. albicans and Candida kefyr growth*                                                             *Fluconazole 400 mg on 1st day followed by 200 mg daily for 2 weeks and esomeprazole magnesium 40 mg for 1 month*   *Almost complete healing of ulcer on 3-week followup EGD. Eradication of H. pylor i afterwards*
  *Ukekwe et al, 2015^\[[@b14-1696-1-13537-1-10-20200519]\]^*     *70, M*                 *Epigastric pain followed by abdominal wall rigidity*    *None*                               *None. Ex-lap revealed 3.1×1 cm gastric perforation covered with fibrinous exudate*                                 *Candida growth (numerous spores and budding hyphae)*                                                                          *Fluconazole, clindamycin, ciprofloxacin, levofloxacin, imipenem*                                                   *Resolution*
  *Goyal et al, 2016^\[[@b15-1696-1-13537-1-10-20200519]\]^*      *45, F*                 *Persistent epigastric pain and vomiting, weight loss*   *NSAID use*                          *Circumferential ulcer at pylorus extending into 1st part of duodenum*                                              *Fungal spores and budding yeast forms of Candida species*                                                                     *Fluconazole 200 mg for 2 weeks*                                                                                    *Small healing clean-based ulcer on 1-month follow-up EGD*
  *Albeiruti, 2020 (our case)*                                    *50, F*                 *Post-prandial abdominal pain, vomiting, weight loss*    *COPD*                               *1 cm irregular shaped ulcer at pylorus*                                                                            *Necroinflammatory debris and fungal consistent with Candida*                                                                  *Fluconazole*                                                                                                       *Resolution*

COPD, chronic obstructive pulmonary disease; EGD, esophagogastroduodenoscopy; ex-lap, exploratory laparotomy; F, female; M, male; NSAID, non-steroidal anti-inflammatory drug; PAS, periodic acid--Schiff; PPI, proton-pump inhibitor.
